Monthly Archives: April 2026

Streamlining assessment of pathological response after neoadjuvant treatment

Neoadjuvant immunotherapy continues to transform outcomes for people with melanoma and other cancers. Two recent papers show that assessing pathological response after neoadjuvant immunotherapy can be both more efficient and more consistent, without compromising accuracy.

By |2026-05-05T18:23:22+10:00April 23rd, 2026|Research News|0 Comments
Go to Top